Conventional chemotherapy was associated with an improvement in the survival of patients with advanced non-small cell lung cancer, a new study found. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the preferred treatment option for patients with advanced non-small cell lung cancer (NSCLC) who have mutations in the EGFR gene. These drug-sensitive mutations are found in about 10 percent of Western patients and almost 50 percent of Asian ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment